| Journal: | Revista de saude publica |
| Database: | |
| System number: | 000535823 |
| ISSN: | 0034-8910 |
| Authors: | Santos, Alcione Miranda dos1 Souza, Bruno Feres de2 Carvalho, Carolina Abreu de1 Campos, Marcos Adriano Garcia1 Oliveira, Bruno Luciano Carneiro Alves de1 Diniz, Eduardo Moraes3 Branco, Maria dos Remédios Freitas Carvalho1 Queiroz, Rejane Christine de Sousa1 Carvalho, Vitória Abreu de1 Araújo, Waleska Regina Machado4 Silva, Antônio Augusto Moura da1 |
| Institutions: | 1Universidade Federal do Maranhão, Programa de Pós-Graduação em Saúde Coletiva, São Luís. Brasil 2Universidade Federal do Maranhão, Departamento de Engenharia da Computação, São Luís. Brasil 3Universidade Federal do Maranhão, Departamento de Física, São Luís. Brasil 4Universidade de São Paulo, Faculdade de Medicina, São Paulo, São Paulo. Brasil |
| Year: | 2021 |
| Volumen: | 55 |
| Country: | Brasil |
| Language: | Inglés |
| English abstract | OBJECTIVE To estimate the 2020 all-cause and COVID-19 excess mortality according to sex, age, race/color, and state, and to compare mortality rates by selected causes with that of the five previous years in Brazil. METHODS Data from the Mortality Information System were used. Expected deaths for 2020 were estimated from 2015 to 2019 data using a negative binomial log-linear model. RESULTS Excess deaths in Brazil in 2020 amounted to 13.7%, and the ratio of excess deaths to COVID-19 deaths was 0.90. Reductions in deaths from cardiovascular diseases (CVD), respiratory diseases, and external causes, and an increase in ill-defined causes were all noted. Excess deaths were also found to be heterogeneous, being higher in the Northern, Center-Western, and Northeastern states. In some states, the number of COVID-19 deaths was lower than that of excess deaths, whereas the opposite occurred in others. Moreover, excess deaths were higher in men aged 20 to 59, and in black, yellow, or indigenous individuals. Meanwhile, excess mortality was lower in women, in individuals aged 80 years or older, and in whites. Additionally, deaths among those aged 0 to 19 were 7.2% lower than expected, with reduction in mortality from respiratory diseases and external causes. There was also a drop in mortality due to external causes in men and in those aged 20 to 39 years. Moreover, reductions in deaths from CVD and neoplasms were noted in some states and groups. CONCLUSION There is evidence of underreporting of COVID-19 deaths and of the possible impact of restrictive measures in the reduction of deaths from external causes and respiratory diseases. The impacts of COVID-19 on mortality were heterogeneous among the states and groups, revealing that regional, demographic, socioeconomic, and racial differences expose individuals in distinct ways to the risk of death from both COVID-19 and other causes. |
| Keyword: | Neoplasms, mortality, Mortality, COVID-19, Cause of Death |
| Full text: | Texto completo (Ver HTML) Texto completo (Ver PDF) |
